[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"#CVKD Exciting news: Cadrenal Therapeutics Company Webcast @ Lytham Partners Fall 2025 Investor Conference. Watch live here:- $TNON $DJT $SMX $XBI $RDFN $NOVV $TIL $SMCI $VSAT $SPY $QQQ $NVDA $MULN $TSLA"
X Link @GuzmanAlic16045 2025-10-20T01:48Z XX followers, XX engagements
""The anti-PD-1 moiety of JS207 adopts a Fab structure to maintain binding affinity to PD-1 and thereby attain better enrichment in the tumor microenvironment". at a cost of a little more tox than other anti-PD-1 Fabs"
X Link @spontonic 2025-10-17T16:53Z XXX followers, XXX engagements
"Today's Top Losers - $GLTO XXXXX% - $BLBX XXXXX% - $HMY XXXXX% - $PAPL XXXXX% - $CJMB XXXXX% - $CURX XXXXX% - $TIL XXXXX% - $TOPP XXXXX% - $ADGM XXXXX% - $WRN XXXXX% - $BNKK XXXXX% - $BULG 10.18%"
X Link @haploapp 2025-10-17T15:30Z XXX followers, XXX engagements
"PD-1 x VEGF news: Shanghai Junshi says it's got FDA approval to start a US ph2/3 trial of JS207 head-to-head vs Opdivo in neoadjuvant NSCLC $SMMT $TIL $BNTX"
X Link @JacobPlieth 2025-10-16T13:06Z 30.9K followers, 7388 engagements